Azenta, Inc.
corporate_fare Company Profile
Azenta, Inc. (NASDAQ:AZTA) is a publicly traded company in the Technology sector. Wiseek has independently scored 23 items for AZTA at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-19, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 12 rated 8 or above. Recent SEC coverage for AZTA spans 10-K, 8-K, 10-Q.
Recent high-impact activity:
- Azenta 10-K: $149M Goodwill Impairment, Adverse ICFR Opinion, $167M Net Loss
- Azenta Q4 Adjusted EPS of 28 Cents Nearly Triples the 11-Cent Consensus
- Azenta Guides FY27 Revenue to $648-$660M as Organic Growth Stalls at 2%
- Azenta Licenses Elegen Gene Synthesis Tech and Buys SynPlexity for GENEWIZ
- Azenta Restructures Multiomics Segment, Closing Three Labs and Cutting Workforce
Financial Snapshot
Short Interest & Short Volume
6.20 days to coverFINRA reported short interest of 5,404,752 shares in AZTA as of the October 30, 2026 settlement, a 0.8% increase from the prior period — about 6.2 days to cover at its recent average daily volume. On November 20, 2026, 58.4% of AZTA volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.